Calcium-dependent inhibition of polo-like kinase 3 activity by CIB1 in breast cancer cells

International Journal of Cancer

Volumn 128, Issue 3, 2011, Pages 587-596

  Naik, Meghna U ^a   Pham, Ngoc T ^a   Beebe, Kristin ^a   Dai, Wei ^b   Naik, Ulhas P ^a,c  

^a UNIVERSITY OF DELAWARE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c Institute University of Delaware Newark   (United States)

Author keywords

breast cancer; calcium and integrin binding protein 1; CIB1; Plk3; polo like kinase 3

Indexed keywords

BINDING PROTEIN; CALCIUM AND INTEGRIN BINDING PROTEIN 1; CALCIUM ION; MESSENGER RNA; POLO LIKE KINASE 3; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CANCER CELL CULTURE; CANCER TISSUE; CELL CYCLE REGULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

BASE SEQUENCE; BREAST NEOPLASMS; CALCIUM; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, DOUBLE-STRANDED; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 78649838512     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25388     Document Type: Article

References (38)

1. Nigg EA,. Polo-like kinases: positive regulators of cell division from start to finish. Curr Opin Cell Biol 1998; 10: 776-83.
2. Eckerdt F, Yuan J, Strebhardt K,. Polo-like kinases and oncogenesis. Oncogene 2005; 24: 267-76.
3. Takai N, Hamanaka R, Yoshimatsu J, Miyakawa I,. Polo-like kinases (Plks) and cancer. Oncogene 2005; 24: 287-91.
4. Clay FJ, McEwen SJ, Bertoncello I, Wilks AF, Dunn AR,. Identification and cloning of a protein kinase-encoding mouse gene. Plk, related to the polo gene of. Drosophila. Proc Natl Acad Sci USA 1993; 90: 4882-6.
5. Donohue PJ, Alberts GF, Guo Y, Winkles JA,. Identification by targeted differential display of an immediate early gene encoding a putative serine/threonine kinase. J Biol Chem 1995; 270: 10351-7.
6. Fode C, Motro B, Yousefi S, Heffernan M, Dennis JW,. Sak, a murine protein-serine/threonine kinase that is related to the Drosophila polo kinase and involved in cell proliferation. Proc Natl Acad Sci USA 1994; 91: 6388-92.
7. Li B, Ouyang B, Pan H, Reissmann PT, Slamon DJ, Arceci R, Lu L, Dai W,. Prk, a cytokine-inducible human protein serine/threonine kinase whose expression appears to be down-regulated in lung carcinomas. J Biol Chem 1996; 271: 19402-8.
8. Simmons DL, Neel BG, Stevens R, Evett G, Erikson RL,. Identification of an early-growth-response gene encoding a novel putative protein kinase. Mol Cell Biol 1992; 12: 4164-9.
9. Glover DM, Hagan IM, Tavares AA,. Polo-like kinases: a team that plays throughout mitosis. Genes Dev 1998; 12: 3777-87.
10. Lee KS, Grenfell TZ, Yarm FR, Erikson RL,. Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk. Proc Natl Acad Sci USA 1998; 95: 9301-6.
11. Roshak AK, Capper EA, Imburgia C, Fornwald J, Scott G, Marshall LA,. The human polo-like kinase. PLK, regulates cdc2/cyclin. B through phosphorylation and activation of the cdc25C phosphatase. Cell Signal 2000; 12: 405-11.
12. Toyoshima-Morimoto F, Taniguchi E, Nishida E,. Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep 2002; 3: 341-8.
13. Jang YJ, Lin CY, Ma S, Erikson RL,. Functional studies on the role of the C-terminal domain of mammalian polo-like kinase. Proc Natl Acad Sci USA 2002; 99: 1984-9.
14. Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA, Medema RH,. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol 2000; 2: 672-6.
15. Johnson EF, Stewart KD, Woods KW, Giranda VL, Luo Y,. Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity. Biochemistry 2007; 46: 9551-63.
16. Kauselmann G, Weiler M, Wulff P, Jessberger S, Konietzko U, Scafidi J, Staubli U, Bereiter-Hahn J, Strebhardt K, Kuhl D,. The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and integrin-binding protein and are regulated dynamically with synaptic plasticity. EMBO J 1999; 18: 5528-39.
17. Ma S, Liu MA, Yuan YL, Erikson RL,. The serum-inducible protein kinase Snk is a G(1) Phase polo-like kinase that is inhibited by the calcium- and integrin-binding protein CIB. Mol Cancer Res 2003; 1: 376-84.
18. Ito Y, Yoshida H, Matsuzuka F, Matsuura N, Nakamura Y, Nakamine H, Kakudo K, Kuma K, Miyauchi A,. Polo-like kinase 1 (PLK1) expression is associated with cell proliferative activity and cdc2 expression in malignant lymphoma of the thyroid. Anticancer Res 2004; 24: 259-63.
19. Kneisel L, Strebhardt K, Bernd A, Wolter M, Binder A, Kaufmann R,. Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease. J Cutan Pathol 2002; 29: 354-8.
20. Smith MR, Wilson ML, Hamanaka R, Chase D, Kung H, Longo DL, Ferris DK,. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun 1997; 234: 397-405.
21. Burns TF, Fei P, Scata KA, Dicker DT, El-Deiry WS,. Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol Cell Biol 2003; 23: 5556-71.
22. Ouyang B, Pan H, Lu L, Li J, Stambrook P, Li B, Dai W,. Human Prk is a conserved protein serine/threonine kinase involved in regulating M phase functions. J Biol Chem 1997; 272: 28646-51.
23. Xie S, Wu H, Wang Q, Cogswell JP, Husain I, Conn C, Stambrook P, Jhanwar-Uniyal M, Dai W,. Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J Biol Chem 2001; 276: 43305-12.
24. Zimmerman WC, Erikson RL,. Polo-like kinase 3 is required for entry into S phase. Proc Natl Acad Sci USA 2007; 104: 1847-52.
25. Naik UP, Patel PM, Parise LV,. Identification of a novel calcium-binding protein that interacts with the integrin alphaIIb cytoplasmic domain. J Biol Chem 1997; 272: 4651-4.
26. Shock DD, Naik UP, Brittain JE, Alahari SK, Sondek J, Parise LV,. Calcium-dependent properties of CIB binding to the integrin alphaIIb cytoplasmic domain and translocation to the platelet cytoskeleton. Biochem J 1999; 342 (Pt 3): 729-35.
27. Naik UP, Naik MU,. Association of CIB with GPIIb/IIIa during outside-in signaling is required for platelet spreading on fibrinogen. Blood 2003; 102: 1355-62.
28. Cui W, Ning J, Naik UP, Duncan MK,. OptiRNAi, an RNAi design tool. Comput Meth Prog Biomed 2004; 75: 67-73.
29. Brummelkamp TR, Bernards R, Agami R,. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-3.
30. Jarman KE, Moretti PA, Zebol JR, Pitson SM,. Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium- and integrin-binding protein 1. J Biol Chem 285: 483-92.
31. Wang Q, Xie S, Chen J, Fukasawa K, Naik U, Traganos F, Darzynkiewicz Z, Jhanwar-Uniyal M, Dai W,. Cell cycle arrest and apoptosis induced by human Polo-like kinase 3 is mediated through perturbation of microtubule integrity. Mol Cell Biol 2002; 22: 3450-9.
32. Elia AE, Rellos P, Haire LF, Chao JW, Ivins FJ, Hoepker K, Mohammad D, Cantley LC, Smerdon SJ, Yaffe MB,. The molecular basis for phosphodependent substrate targeting and regulation of plks by the polo-box domain. Cell 2003; 115: 83-95.
33. Conn CW, Hennigan RF, Dai W, Sanchez Y, Stambrook PJ,. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3. Cancer Res 2000; 60: 6826-31.
34. Dai W, Liu T, Wang Q, Rao CV, Reddy BS,. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors. Int J Oncol 2002; 20: 121-6.
35. Xie S, Wang Q, Wu H, Cogswell J, Lu L, Jhanwar-Uniyal M, Dai W,. Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3. J Biol Chem 2001; 276: 36194-9.
36. Yang Y, Bai J, Shen R, Brown SA, Komissarova E, Huang Y, Jiang N, Alberts GF, Costa M, Lu L, Winkles JA, Dai W,. Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions. Cancer Res 2008; 68: 4077-85.
37. Bahassi el M, Conn CW, Myer DL, Hennigan RF, McGowan CH, Sanchez Y, Stambrook PJ,. Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene 2002; 21: 6633-40.
38. Holtrich U, Wolf G, Yuan J, Bereiter-Hahn J, Karn T, Weiler M, Kauselmann G, Rehli M, Andreesen R, Kaufmann M, Kuhl D, Strebhardt K,. Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages. Oncogene 2000; 19: 4832-9.